16 January 2018

A large consortium led by the University of Tübingen, the Radboud university medical center Nijmegen and the University of Leicester has acquired a € 15 million grant for the SOLVE-RD research program. The consortium will use the funding to improve the diagnosis of rare diseases. The researchers will work directly with four European reference networks (or ERNs): European networks of care providers set up to share and enhance the knowledge and resources used for treating rare diseases.

Patients with a rare disease generally go through a long and arduous process, sometimes lasting ten or fifteen years (also known as the rare disease odyssey), before finding a physician who knows what is wrong with them. Scientific advances can also take a long time, as it is difficult to find sufficient numbers of people with the same rare disease to enable successful research.

No diagnosis

Collectively rare diseases are common. While for a given rare disease, the number of people will be extremely low, the very large number of such rare diseases means that collectively, their number in Europe runs into hundreds of thousands. In recent years, it has become clear that the ‘eye’ of a doctor alone often will not suffice to diagnose a rare disease. We need better genetic tests to effectively diagnose rare diseases.

Commitment

This is where SOLVE-RD, a large-scale research program operating under the European Commission’s Horizon 2020, comes in. The academic partners taking part in SOLVE-RD have designed an infrastructure enabling the coordination and analysis of all data generated across Europe.
 
Combining the existing exome and genome patient data of all collaborators of SOLVE-RD greatly increases the chances of finding a second or a third patient with the same rare disease. The commitment for sharing data on rare diseases on this scale is unique.

Data as never seen before

But SOLVE-RD goes a few steps further by applying the latest available ‘multi-omics’ methods. If the DNA data illuminate a particular disease, researchers turn to other large scale tests that reflect the gene’s function such as RNA, the proteins (proteomics), metabolic products (metabolomics) and epigenomics. Combining these ‘…omics’ techniques provides the extra information that may ensure that a rare disease is diagnosed. The enormous amount of data resulting from this multi-omics approach must be converted into useful, comprehensible information by bioinformatic scientists using smart algorithms.

Virtual networks

SOLVE-RD is a unique project, because the research for better diagnostics of rare diseases is directly linked to better care at the European level in 24 Reference Networks (ERNs). These ERNs were set up to improve and harmonize diagnosis and treatment for people suffering from rare diseases. Using shared knowledge and guidelines, a patient in Romania, for example, will receive the same diagnostics and treatment as a patient in Sweden or Spain. The virtual networks collectively pool all existing knowledge and remove unnecessary boundaries.

Diagnostics of the future

SOLVE-RD comprises four ERNs for rare neurological diseases (RND), neuromuscular diseases (EURO-NMD), congenital malformations and intellectual disability (ITHACA) and genetic tumor risk syndromes (GENTURIS). These ERNs are the first to add and share their patient data, thereby taking the lead in improving the diagnosis and treatment of these rare diseases. Other ERNs will join SOLVE-RD later. In this way, SOLVE-RD will have a significant impact on our knowledge and clinical practice when it comes to diagnosing and treating rare diseases in Europe.

The role of Radboud university medical center in SOLVE-RD

Nicoline Hoogerbrugge (leader of ERN-GENTURIS): “This really empowers patients with hereditary cancer, finding the molecular diagnosis is of great importance for treatment of the patients and prevention of cancer in relatives."
Han Brunner (co-coordinator of SOLVE-RD): "It is a unique emphasis that so many researchers share so much data of so many rare disease patients to boost novel discoveries. Via the involved ERNs we assemble a lot of the rare disease experts from all over Europe."
Alexander Hoischen (workpackage leader SOLVE-RD): "It is exciting to explore the best tests for patients with rare diseases. The human genetic department of the Radboud university center in Nijmegen has always been at the forefront of translating latest genomic tools from research towards diagnostics. With this consortium we can continue to do so with many valued European partners."

Read here an interview that Alexander Hoischen gave to GenomeWeb about SOLVE-RD.
 
SOLVE-RD: link
H2020 program: link
ERNs:
- Europa networks: link
- Eurordis: link

Related news items


More expertise needed for patients with prolonged Disorder of Consciousness

14 November 2019

Willemijn van Erp published in the Annals of Neurology that nearly 80% of people with Unresponsive Wakefulness Syndrome, formerly referred to as ‘vegetative state’, are not given a correct description of the diagnosis when they are discharged from the hospital.

read more

Martinus van Marum prize call for proposals

14 November 2019

The Martinus van Marum prize is given to young researchers (<5 years after PhD) for the original research they have conducted in science and technology.

read more

1.5 million for research into young people with mild intellectual disabilities

13 November 2019

Researchers from the Radboud University and Radboudumc will partner with social organisations to map how often young people with mild intellectual disabilities have psychological problems and how they can be treated. The project was recently awarded a subsidy of 1.5 million euro by ZonMw.

read more

Bart van de Warrenburg appointed visiting professor at the UKM Medical Centre in Kuala Lumpur

11 November 2019

Neurologist and Principal Investigator at the Donders Institute Bart van de Warrenburg has been appointed visiting professor at the UKM Medical Centre in Kuala Lumpur.

read more

KNAW Van Leersum beurs for Mohammad Alsady

7 November 2019

Mohammad Alsady, theme Disorders of movement, received the “KNAW Van Leersum beurs”.

read more

3D breast ultrasound elastography to improve breast cancer detection

5 November 2019

One out of seven women will be diagnosed with breast cancer during their life. Early detection of breast cancer is important to increase the survival rate. Gijs Hendriks graduated recently on a new technique, 3D elastography, to detect breast cancer better.

read more